Analyst Ratings for ARIAD Pharmaceuticals (ARIA)

ARIA Rating Summary

ARIA Price Target Summary

  |   Expand Research on ARIA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $24.59 (+47.5%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/28/2013 Goldman Sachs New Coverage Neutral
(N/A)
20.00
(N/A)
18.31 16.67 -8.96% Details
2/8/2013 JMP Securities New Coverage Market Outperform
(N/A)
32.00
(N/A)
19.80 16.67 -15.81% Details
11/9/2012 Guggenheim New Coverage Buy
(N/A)
30.00
(N/A)
20.76 16.67 -19.7% Details
10/26/2012 Citi New Coverage Buy
(N/A)
31.00
(N/A)
21.97 16.67 -24.12% Details
10/23/2012 Oppenheimer
» Updated 1/3/2013
Downgrade Perform
(Outperform)
23.00
(23.00)
22.79 16.67 -26.85% Details
9/10/2012 BofA/Merrill Lynch Upgrade Buy
(Neutral)
N/A
(N/A)
22.01 16.67 -24.26% Details
7/30/2012 William Blair New Coverage Outperform
(N/A)
25.00
(N/A)
18.92 16.67 -11.89% Details
4/12/2012 UBS
» Updated 10/2/2012
New Coverage Buy
(N/A)
29.00
(23.00)
15.14 16.67 10.11% Details
3/15/2012 Stifel Nicolaus New Coverage Buy
(N/A)
19.00
(N/A)
15.12 16.67 10.25% Details
2/14/2012 RBC Capital
» Updated 9/21/2012
New Coverage Outperform
(N/A)
28.00
(23.00)
15.25 16.67 9.31% Details
1/19/2012 Maxim Group New Coverage Buy
(N/A)
20.00
(N/A)
14.45 16.67 15.36% Details
12/9/2011 Barclays
» Updated 10/22/2012
New Coverage Equalweight
(N/A)
30.00
(25.00)
11.15 16.67 49.51% Details
10/14/2011 Rodman & Renshaw New Coverage Market Outperform
(N/A)
15.00
(N/A)
9.94 16.67 67.71% Details
9/8/2011 BMO Capital New Coverage Outperform
(N/A)
18.00
(N/A)
9.89 16.67 68.55% Details
8/25/2011 Summer Street New Coverage Buy
(N/A)
16.00
(N/A)
8.83 16.67 88.79% Details
Like ARIA Ratings? Also take a look at SNE, AAPL, MRK, GOL

ARIA Ratings News